According to Blakeley's expectations, there could be healthcare deliveries sometime in the next 3 months, should all things be on track. He has delivered on the "major" European airline promises and hopefully the healthcare trials move forward into direct sales. While we all know things can change, we remain within his timeframe for delivery. From that I surmise healthcare is still very much on the table.

Gaining traction with the eVU outside of IFE will be a very big step forward for continued growth on the eVU front, imo.

An annual shareholders meeting with Blakeley being able to talk about this development, further IFE wins, Vivitar and beyond should be quite compelling.

I'm happy to wait a few more months for a far more meaningful shareholders meeting rather than push one through just to vote for new board members and rehash what we already know.